Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Journal of Cardiovascular Pharmacology|June 27, 2003
In vivo canine cardiac electrophysiologic profile of 1,4-benzodiazepine IKs blockersGary L Stump, Garry R Smith, Andrew J Tebben, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 18, 2002
Antiarrhythmic efficacy of combined I(Ks) and beta-adrenergic receptor blockadeJoseph J Lynch, Joseph J Salata, Audrey A Wallace, et al.
Bioorganic & Medicinal Chemistry Letters|April 15, 2004
Imidazole acetic acid TAFIa inhibitors: SAR studies centered around the basic P(1)(') groupPhilippe G Nantermet, James C Barrow, Stacey R Lindsley, et al.
Bioorganic & Medicinal Chemistry Letters|November 23, 2006
Beta-secretase (BACE-1) inhibitors: accounting for 10s loop flexibility using rigid active sitesGeorgia B McGaughey, Dennis Colussi, Samuel L Graham, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2013
(E)-Alkenes as replacements of amide bonds: development of novel and potent acyclic CGRP receptor antagonistsJune J Kim, Michael R Wood, Shawn J Stachel, et al.
Bioorganic & Medicinal Chemistry Letters|September 21, 2010
Novel CGRP receptor antagonists from central amide replacements causing a reversal of preferred chiralityMichael R Wood, Kathy M Schirripa, June J Kim, et al.
Bioorganic & Medicinal Chemistry Letters|July 23, 2003
Design and synthesis of potent and selective macrocyclic thrombin inhibitorsPhilippe G Nantermet, James C Barrow, Christina L Newton, et al.
Bioorganic & Medicinal Chemistry Letters|January 22, 2011
Orally bioavailable imidazoazepanes as calcitonin gene-related peptide (CGRP) receptor antagonists: discovery of MK-2918Daniel V Paone, Diem N Nguyen, Anthony W Shaw, et al.
Bioorganic & Medicinal Chemistry Letters|January 30, 2002
Discovery of a nonpeptidic small molecule antagonist of the human platelet thrombin receptor (PAR-1)Philippe G Nantermet, James C Barrow, George F Lundell, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 2003
Unexpected enhancement of thrombin inhibitor potency with o-aminoalkylbenzylamides in the P1 positionKenneth E Rittle, James C Barrow, Kellie J Cutrona, et al.
Pageof 4